Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression

Journal of Neuroscience Research

Volumn 58, Issue 4, 1999, Pages 593-598

  Serou, Michael J ^a   DeCoster, Mark A ^a   Bazan, Nicolas G ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

BN50730; COX 2; IL 1 ; Neurons; PAF; Seizures

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; ENZYME ACTIVITY; ENZYME INDUCTION; HIPPOCAMPUS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AZEPINES; CYCLOOXYGENASE 2; ENZYME INDUCTION; HIPPOCAMPUS; INTERLEUKIN-1; ISOENZYMES; MICE; NEURONS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RECOMBINANT PROTEINS; TRIAZOLES;

EID: 0033571376     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991115)58:4<593::AID-JNR12>3.0.CO;2-4     Document Type: Article

References (45)

1. 2 production and sphingomyelin metabolism. J Biol Chem 267:20044-20050.
2. Bankers-Fulbright JL, Kalli KR, McKean DJ. 1996. Interleukin-1 signal transduction. Life Sci 59:61-83.
3. Bazan NG, Black B. 1999. Synaptic signaling dysfunction in status epilepticus: injury messenger gene expression. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, editors. Advances in neurology: status epilepticus. New York: Lippincott-Raven Publishers, (in press).
4. Bazan NG, Serou M. 1999. Second messengers, long-term potentiation, gene expression and epileptogenesis. In: Delgado-Escueta AV, Watson WA, Olsen RW, Porter RJ, editors. Jasper's basic mechanisms of the epilepsies, third edition: advances in neurology, vol 79. Philadelphia: Lippincott Williams & Wilkins. (in press).
5. Bazan NG, Squinto SP, Braquet P, Panetta T, Marcheselli VL. 1991. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a FOS/JUN/AP-1 transcriptional signaling system. Lipids 26:1236-1242.
6. Bazan NG, Fletcher BS, Herschman HR, Mukherjee PK. 1994. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci USA 91:5252-5256.
7. Bussolino F, Arese M, Silvestro L, Soldi R, Benfenati E, Sanavio F, Aglietta M, Bosia A, Camussi G. 1994. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-alpha or interleukin-1 alpha. Eur J Immunol 24:3131-3139.
8. Clark GD, Happel LT, Zorumski CF, Bazan NG. 1992. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9:1211-1216.
9. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. 1998. An assessment of the effects of central interleukin-1 beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84:923-933.
10. Cunningham AJ, Murray CA, O'Neill LAJ, Lynch MA, O'Connor JJ. 1996. Interleukin-1 beta (IL-1 beta) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20.
11. Cunningham ET Jr, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB. 1992. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 12:1101-1114.
12. DeCoster MA, Mukherjee PK, Davis RJ, Bazan NG. 1998. Platelet-activating factor as a downstream messenger of kainate-induced activation of MAP kinases in primary hippocampal neurons. J Neurosci Res 53:297-303.
13. Dinarello CA. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16:457-499.
14. Gilboe DD, Kintner D, Fitzpatrick JH, Emoto SE, Esanu A, Braquet PG, Bazan NG. 1991. Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists. J Neurochem 56:311-319.
15. Gill PS, Regmi A, Porter-Gill PA, Kasckow JW. 1998. Inlerleukin-1 regulation of corticotropin-releasing factor (CRF), glucocorticoid receptor, c-fos and c-jun messenger RNA in the NPLC-KC cell line. Mol Cell Endocrinol 137:31-39.
16. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR. 1998. Interleukin-1 beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 273:28670-28676.
17. Hansen MK, Taishi P, Chen Z, Krueger JM. 1998. Vagotomy blocks the induction of interleukin-1 beta(IL-1 beta) mRNA in the brain of rats in response to systemic IL-1 beta. J Neurosci 18:2247-2253.
18. Heneka MT, Löschmann P-A, Gleichmann M, Weller M, Scholz JB, Wullner U, Klockgether T. 1998. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem 71:88-94.
19. Hirata F, Lee JY, Sakamoto T, Nomura A, Uchida Y, Hirata A, Hasegawa S. 1994. IL-1 beta regulates the expression of the Gi2 alpha gene via lipid mediators in guinea pig tracheal muscle. Biochem Biophys Res Commun 203:1889-1896.
20. Ikeda J, Ochiai K, Morita I, Murota S. 1993. Endogenous nitric oxide blocks calcium influx induced by glutamate in neurons contain ing NADPH diaphorase. Neurosci Lett 158:193-196.
21. Jeohn G-H, Kong L-Y, Wilson B, Hudson P, Hong J-S. 1998. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10.
22. 1 hippocampal long-term potentiation. Nature 367:175-179.
23. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M. 1990. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharm 181:323-326.
24. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at post-synaptic sites in rat cerebral cortex. Proc Natl Acad Sci 93:2317-2321.
25. Koh J-Y, Peters S, Choi DW. 1986. Neurons containing nadphdiaphorase are selectively resistant to quinolate toxicity. Science 234:73-76.
26. 2) in thrombin-stimulated platelets. J Biol Chem 271:27723-27729.
27. Kuno K, Matsushima K. 1994. The IL-1 receptor signaling pathway. J Leukocyte Biol 56:542-547.
28. Kwon G, Corbett JA, Hauser S, Hill JR, Turk J, McDaniel ML. 1998. Evidence for involvement of the proteasome complex (26S) and NFΚB in IL-1 beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes 47:583-591.
29. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S. 1990. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res 514:135-140.
30. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
31. Lukiw WJ, Pelaez RP, Martinez J, Bazan NG. 1998. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin-1 beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epithelial keratinocytes. Proc Nat Acad Sci USA 95:3914-3919.
32. Maiese K, Wagner J, Boccone L. 1994. Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade. Neurosci Lett 166:43-47.
33. Marcheselli VL, Bazan NG. 1996. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. J Biol Chem 271:24794-24799.
34. Marks-Konczalik J, Chu SC, Moss J. 1998. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kB-binding sites. J Biol Chem 273:22201-22208.
35. 2 activity of naive and sensitized guinea-pig alveolar macrophages. Br J Pharm 122:1345-1352.
36. Mukherjee PK, DeCoster MA, Campbell FZ, Davis RJ, Bazan NG. 1999. Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. J Biol Chem 274:6493-6498.
37. Nogawa S, Zhang F, Ross ME, Iadecola C. 1997. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17:2746-2755.
38. Panetta T, Marcheselli VL, Braquet P, Bazan NG. 1987. Effects of a platelet-activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem Biophys Res Commun 149:580-587.
39. Rossi AG, Cousin JM, Dransfeld I, Lawson MF, Chilvers ER, Haslett C. 1995. Agents that elevate cAMP inhibit human neutrophil apoptosis. Bioch Biophys Res Comm 217:892-899.
40. Rothwell N, Allan S, Toulmond S. 1997. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 100:2648-2652.
41. Schneider H, Pitossi F, Balschum D, Wagner A, Del Rey A, Besedovsky HO. 1998. A neuromodulatory role of interleukin-1 beta in the hippocampus. Proc Nat Acad Sci USA 95:7778-7783.
42. 2 in Human colon cancer cells. Cancer Res 58:362-366.
43. Shi L-C, Wang H-Y, Friedman E. 1998. Involvement of platelet-activating factor in cell death induced under ischemia/ postischemia-like conditions in an immortalized hippocampal cell line. J Neurochem 70:1035-1044.
44. Stylianou E, Saklatvala J. 1998. Interleukin-1. Int J Biochem Cell Biol 30:1075-1079.
45. Xie Q, Kashiwabara Y, Nathan C. 1994. Role of transcription factor NFΚB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708.